Entering text into the input field will update the search result below

Neoleukin Therapeutics announces 1-for-5 reverse stock split

Sep. 22, 2023 1:13 PM ETNeoleukin Therapeutics, Inc. (NLTX)By: Tiyashi Datta, SA News Editor
  • Neoleukin Therapeutics (NASDAQ:NLTX) on Friday announced a reverse stock split of the company’s outstanding shares of common stock at a ratio of 1-for-5.
  • The reverse stock split is part of Neoleukin’s plan to regain compliance with Nasdaq’s minimum bid price requirement of $1.00 per share.
  • Neoleukin’s common stock will begin trading on a post-reverse stock split basis on September 25, under Neoleukin’s existing trading symbol "NLTX".
  • NLTX is -0.92% to $0.6925.
  • Source: Press Release

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About NLTX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Neoleukin Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Gain Therapeutics, Inc.
Cyclo Therapeutics, Inc.
NextCure, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.